Elizabeth M. Rosethorne

Author

Novartis (United Kingdom)ORCID

Also Known As

E M Rosethorne, Elizabeth M Rosethorne, Elizabeth M. Rosethorne, Elizabeth Rosethorne, ElizabethM. Rosethorne

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Novartis (United Kingdom)University of Nottingham Queen's Medical Centre Novartis (Switzerland)University of Leicester

About

Elizabeth M. Rosethorne is an author at Novartis (United Kingdom) specializing in medicine, pharmacology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	191
2	Cell Biology	3	3	59
3	Biochemistry	2	2	44
4	Cellular Physiology	2	2	46
5	Natural Sciences	1	1	12

Elizabeth M. Rosethorne

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
μ-Opioid Receptors: Correlation of Agonist Efficacy for Signalling with Ability to Activate Internalization Jamie McPherson, Guadalupe Rivero, Myma Baptist, Molecular Pharmacology	2010	266
The M <sub>3</sub> -muscarinic receptor regulates learning and memory in a receptor phosphorylation/arrestin-dependent manner Benoit Poulin, Adrian J. Butcher, Phillip McWilliams, Proceedings of the National Academy of Sciences	2010	143
Agonist-Biased Signaling at the Histamine H4 Receptor: JNJ7777120 Recruits β-Arrestin without Activating G Proteins Elizabeth M. Rosethorne, Steven J. Charlton Molecular Pharmacology	2010	114
M <sub>3</sub> -muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1 Kok Choi Kong, Adrian J. Butcher, Phillip McWilliams, Proceedings of the National Academy of Sciences	2010	100
Endomorphin-2: A Biased Agonist at the μ-Opioid Receptor Guadalupe Rivero, Javier Llorente, Jamie McPherson, Molecular Pharmacology	2012	98
Analysis of Multiple Histamine H4 Receptor Compound Classes Uncovers Gαi Protein- and β-Arrestin2-Biased Ligands Saskia Nijmeijer, Henry F. Vischer, Elizabeth M. Rosethorne, Molecular Pharmacology	2012	50
Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs Sophie J. Bradley, Colin Molloy, Paulina Valuskova, Nature Chemical Biology Molecular PharmacologyFunctional SelectivityMedicineMechanism Of ActionReceptor (Biochemistry)	2020	46
Efficacy is a contributing factor to the clinical onset of bronchodilation of inhaled β2-adrenoceptor agonists Elizabeth M. Rosethorne, Robert Turner, Robin A. Fairhurst, Naunyn-Schmiedeberg s Archives of Pharmacology AsthmaInhaled β2-Adrenoceptor AgonistsLung InflammationMedicineClinical Onset	2010	42
Detailed analysis of biased histamine<scp>H</scp><scp><sub>4</sub></scp>receptor signalling by<scp>JNJ</scp>7777120 analogues Saskia Nijmeijer, Henry F. Vischer, Francesco Sirci, British Journal of Pharmacology	2013	39
Regulation of cyclic AMP response-element binding-protein (CREB) by Gq/11-protein-coupled receptors in human SH-SY5Y neuroblastoma cells Elizabeth M. Rosethorne, Stefan R. Nahorski, R. A. John Challiss Biochemical Pharmacology Synaptic TransmissionNeurotransmitterSynaptic SignalingCellular PhysiologySignaling Pathway	2007	34

Page 1